A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients

Journal of Clinical Psychopharmacology

Volumn 17, Issue 3, 1997, Pages 161-168

  Armitage, Roseanne ^a   Yonkers, Kimberly ^a   Cole, Darwynn ^a   John Rush, A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INSOMNIA; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP; SLEEP DISORDER; SOMNOLENCE; VERTIGO; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SEROTONIN UPTAKE INHIBITORS; SLEEP STAGES; SLEEP, REM; TRIAZOLES;

EID: 0031003655     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199706000-00004     Document Type: Article

References (19)

1. Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995; 56[suppl6]:3-11.
2. Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990;26:311-5.
3. Ware JC, Rose FV, McBrayer RH. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 1994;17:544-50.
4. Sharpley AL, Walsh AES, Cowen PJ. Nefazodone - a novel antidepressant - may increase REM sleep. Biol Psychiatry 1992;31: 1070-3.
5. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994;10:123-7.
6. Sandor P, Shapiro CM. Sleep patterns in depression and anxiety: theory and pharmacological effects. J Psychosom Res 1994; 38[suppl 1]:125-39.
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
8. Spitzer RL, Williams JBW, Gibbons M. The structured clinical interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, 1986.
9. Rechtschaffen A, Kales A, eds. A manual of standardized terminology. Techniques and scoring for sleep stages of human subjects. Bethesda, MD: Neurologic Information Network, NIH Public Health Service, 1968.
10. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Bums C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986;18:65-87.
11. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996;26:477-86.
12. Armitage R, Trivedi M, Rush AJ. Fluoxetine and oculomotor activity during sleep in depressed patients. Neuropsychopharmacology 1995;12:159-65.
13. Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 1990;14:49-63.
14. Vogel GW. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry 1983;7:43-9.
15. Kerkhofs M, Rielaert C, de Maertelaer V, Linkowski P, Czarka M, Mendlewicz J. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables. Int Clin Psychopharmacol 1990;5:253-60.
16. Hendrickse WA, Roffwarg HP, Grannemann BD, Linkowski P, Czarka M, Mendlewicz J. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacology 1994;10:85-91.
17. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55:234-41.
18. Rickels K, Schweizer E, Clary C, Fox I, Weise C. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164:802-5.
19. Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatry 1995;56[suppl 6]:30-6.